Sánchez-Margalet Víctor, Rodriguez-Oliva Manuel, Sánchez-Pozo Cristina, Fernández-Gallardo María Francisca, Goberna Raimundo
Department of Clinical Biochemistry, Virgen Macarena University Hospital, Seville, Spain.
Clin Chem Lab Med. 2005;43(8):876-9. doi: 10.1515/CCLM.2005.147.
Portable meters for blood glucose concentrations are used at the patients bedside, as well as by patients for self-monitoring of blood glucose. Even though most devices have important technological advances that decrease operator error, the analytical goals proposed for the performance of glucose meters have been recently changed by the American Diabetes Association (ADA) to reach <5% analytical error and <7.9% total error. We studied 80 meters throughout the Virgen Macarena Hospital and we found most devices with performance error higher than 10%. The aim of the present study was to establish a new system to control portable glucose meters together with an educational program for nurses in a 1200-bed University Hospital to achieve recommended analytical goals, so that we could improve the quality of diabetes care. We used portable glucose meters connected on-line to the laboratory after an educational program for nurses with responsibilities in point-of-care testing. We evaluated the system by assessing total error of the glucometers using high- and low-level glucose control solutions. In a period of 6 months, we collected data from 5642 control samples obtained by 14 devices (Precision PCx) directly from the control program (QC manager). The average total error for the low-level glucose control (2.77 mmol/l) was 6.3% (range 5.5-7.6%), and even lower for the high-level glucose control (16.66 mmol/l), at 4.8% (range 4.1-6.5%). In conclusion, the performance of glucose meters used in our University Hospital with more than 1000 beds not only improved after the intervention, but the meters achieved the analytical goals of the suggested ADA/National Academy of Clinical Biochemistry criteria for total error (<7.9% in the range 2.77-16.66 mmol/l glucose) and optimal total error for high glucose concentrations of <5%, which will improve the quality of care of our patients.
便携式血糖仪用于患者床边,也供患者自我监测血糖。尽管大多数设备在技术上有重要进步,可减少操作误差,但美国糖尿病协会(ADA)最近改变了血糖仪性能的分析目标,要求分析误差<5%,总误差<7.9%。我们在整个比贞·马卡雷纳医院研究了80台血糖仪,发现大多数设备的性能误差高于10%。本研究的目的是在一家拥有1200张床位的大学医院建立一个新的系统来控制便携式血糖仪,并为护士开展一个教育项目,以实现推荐的分析目标,从而提高糖尿病护理质量。在对负责即时检验的护士进行教育项目后,我们使用了与实验室在线连接的便携式血糖仪。我们通过使用高、低水平血糖控制溶液评估血糖仪的总误差来评估该系统。在6个月的时间里,我们从14台设备(Precision PCx)直接从控制程序(质量控制管理器)获得的5642个对照样本中收集了数据。低水平血糖控制(2.77 mmol/L)的平均总误差为6.3%(范围为5.5 - 7.6%),高水平血糖控制(16.66 mmol/L)的平均总误差更低,为4.8%(范围为4.1 - 6.5%)。总之,我们这家拥有1000多张床位的大学医院使用的血糖仪性能在干预后不仅有所改善,而且达到了ADA/国家临床生物化学学会建议的总误差分析目标(葡萄糖浓度在2.77 - 16.66 mmol/L范围内<7.9%)以及高血糖浓度的最佳总误差<5%,这将提高我们患者的护理质量。